CLASS II ONGOING Device recall · Reported 18 Dec 2024 · FDA Enforcement Report

Liaison Q.S.E.T. Device Plus recalled by Diasorin

Diasorin is recalling Liaison Q.S.E.T. Device Plus. The recall was initiated on 7 Nov 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI/DI 80567713190605F, Lot Numbers: 225084, 232094, 234114, 259144, 221214, 252244, 230094, 224124, 205144, 228174, 228224, 223274, 219104, 217134, 233154, 236174, 224244, 232294, 229224, 251234, 221294, 210204, 223244, 222314
Quantity recalled21905 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0677-2025
FDA event ID
95829
Recalling firm
Diasorin, Stillwater, MN
Classification
Class II
Status
Ongoing
Recall initiated
7 Nov 2024
FDA classified
12 Dec 2024
Reported
18 Dec 2024
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Packaging Defects

Timeline

7 Nov 2024Recall initiated by company
12 Dec 2024Classified by FDA+35 days
18 Dec 2024Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Customer complaints were received alleging leaking devices and insufficient buffer volume. Diasorin's internal investigation determined that 0.14% of the LIAISON Q.S.E.T. Device Plus in the lots identified have loose clear caps, which may allow buffer to leak from the tube. A stool sample prepared with less than the correct amount of buffer may result an incorrectly high patient result.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

DiaSorin LIAISON Q.S.E.T. Device Plus, REF 319060; intended for use in the preparation of human stool specimens

Where it was distributed

Worldwide

Questions about this recall

Why was it recalled?

Customer complaints were received alleging leaking devices and insufficient buffer volume. Diasorin's internal investigation determined that 0.14% of the LIAISON Q.S.E.T. Device Plus in the lots identified have loose clear caps, which may allow buffer to leak from the tube. A stool sample prepared with less than the correct amount of buffer may result an incorrectly high patient result.

Which lots are affected?

UDI/DI 80567713190605F, Lot Numbers: 225084, 232094, 234114, 259144, 221214, 252244, 230094, 224124, 205144, 228174, 228224, 223274, 219104, 217134, 233154, 236174, 224244, 232294, 229224, 251234, 221294, 210204, 223244, 222314

Where was it sold?

Worldwide

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Diasorin

All 6

Other Other Medical Devices recalls

All 13,908